Ampio jumps on Phase III OA data

Shares of Ampio Pharmaceuticals Inc. (NYSE:AMPE) leapt $0.82 (15%) to $6.18 on Wednesday after the company reported that single intra-articular injections of Ampion met the primary endpoint of reducin...